| 1.9 |
7.6 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.7 |
2.2 |
GO:1904956 |
regulation of midbrain dopaminergic neuron differentiation(GO:1904956) regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
| 0.6 |
3.8 |
GO:0006570 |
tyrosine metabolic process(GO:0006570) |
| 0.6 |
1.7 |
GO:0008228 |
opsonization(GO:0008228) modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.5 |
1.6 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.5 |
1.6 |
GO:0090425 |
hepatocyte cell migration(GO:0002194) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
| 0.4 |
2.3 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.4 |
1.8 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.3 |
6.6 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.3 |
1.0 |
GO:0060060 |
post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 0.3 |
1.0 |
GO:1904742 |
protein poly-ADP-ribosylation(GO:0070212) regulation of telomeric DNA binding(GO:1904742) |
| 0.3 |
0.9 |
GO:2001139 |
negative regulation of postsynaptic membrane organization(GO:1901627) negative regulation of dendritic spine maintenance(GO:1902951) negative regulation of phospholipid efflux(GO:1902999) regulation of lipid transport across blood brain barrier(GO:1903000) negative regulation of lipid transport across blood brain barrier(GO:1903001) positive regulation of lipid transport across blood brain barrier(GO:1903002) negative regulation of phospholipid transport(GO:2001139) |
| 0.3 |
0.9 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.3 |
1.3 |
GO:0021856 |
cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
| 0.3 |
0.8 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 0.2 |
1.4 |
GO:2000343 |
positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
| 0.2 |
1.2 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.2 |
0.5 |
GO:2001187 |
positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 0.2 |
1.4 |
GO:1903056 |
regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 0.2 |
1.4 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.2 |
2.2 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.2 |
1.3 |
GO:2000809 |
positive regulation of synaptic vesicle clustering(GO:2000809) |
| 0.2 |
1.1 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.2 |
0.6 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) |
| 0.2 |
1.0 |
GO:0032911 |
nerve growth factor production(GO:0032902) negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.2 |
0.4 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 0.2 |
0.7 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.2 |
0.5 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.2 |
0.7 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.2 |
0.5 |
GO:0071336 |
lung growth(GO:0060437) positive regulation of fat cell proliferation(GO:0070346) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 0.2 |
0.3 |
GO:2000974 |
negative regulation of pro-B cell differentiation(GO:2000974) |
| 0.2 |
0.6 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) |
| 0.2 |
0.5 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 0.1 |
0.7 |
GO:0010991 |
regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.1 |
0.4 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.1 |
0.4 |
GO:0003278 |
apoptotic process involved in heart morphogenesis(GO:0003278) regulation of vascular wound healing(GO:0061043) glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
| 0.1 |
0.5 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.1 |
0.5 |
GO:0071139 |
resolution of recombination intermediates(GO:0071139) |
| 0.1 |
0.4 |
GO:0002035 |
brain renin-angiotensin system(GO:0002035) |
| 0.1 |
0.4 |
GO:0032513 |
negative regulation of protein phosphatase type 2B activity(GO:0032513) |
| 0.1 |
1.3 |
GO:2000671 |
regulation of motor neuron apoptotic process(GO:2000671) |
| 0.1 |
0.1 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.1 |
2.4 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.1 |
0.5 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.1 |
0.4 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.1 |
0.4 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
| 0.1 |
1.1 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.1 |
0.5 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.1 |
0.3 |
GO:0042420 |
dopamine catabolic process(GO:0042420) |
| 0.1 |
0.5 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.1 |
0.7 |
GO:0007195 |
adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.1 |
4.0 |
GO:0042773 |
ATP synthesis coupled electron transport(GO:0042773) |
| 0.1 |
3.5 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.1 |
0.8 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.1 |
0.3 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.1 |
0.4 |
GO:0006538 |
glutamate catabolic process(GO:0006538) |
| 0.1 |
1.6 |
GO:0034308 |
primary alcohol metabolic process(GO:0034308) |
| 0.1 |
0.4 |
GO:0060527 |
prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.1 |
0.4 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.1 |
0.9 |
GO:2001214 |
positive regulation of vasculogenesis(GO:2001214) |
| 0.1 |
0.3 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 0.1 |
0.2 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.1 |
0.4 |
GO:0007171 |
cardiac conduction system development(GO:0003161) activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 |
1.1 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.1 |
0.2 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 |
0.6 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.1 |
0.9 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.1 |
0.2 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.1 |
0.2 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.1 |
0.2 |
GO:0060489 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.1 |
0.2 |
GO:0045602 |
negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.1 |
0.2 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
| 0.1 |
1.2 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.1 |
0.2 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.1 |
0.5 |
GO:0097460 |
positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) ferrous iron import into cell(GO:0097460) |
| 0.1 |
0.2 |
GO:0035633 |
maintenance of blood-brain barrier(GO:0035633) |
| 0.1 |
1.1 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.1 |
0.3 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.1 |
0.6 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
0.9 |
GO:0051482 |
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.1 |
0.3 |
GO:0060686 |
regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
| 0.1 |
1.3 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.1 |
1.5 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.1 |
1.9 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.1 |
0.8 |
GO:0032570 |
response to progesterone(GO:0032570) |
| 0.1 |
0.4 |
GO:0002488 |
antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
| 0.1 |
3.1 |
GO:0007528 |
neuromuscular junction development(GO:0007528) |
| 0.1 |
0.5 |
GO:0030449 |
regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
| 0.1 |
0.7 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
| 0.1 |
0.4 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.1 |
0.2 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.1 |
1.5 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
| 0.1 |
0.3 |
GO:1902861 |
vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) ferrous iron import(GO:0070627) copper ion import into cell(GO:1902861) |
| 0.1 |
0.8 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
| 0.1 |
0.9 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.1 |
0.7 |
GO:0061050 |
regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
| 0.1 |
0.5 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 |
1.2 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.3 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.0 |
0.2 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.0 |
0.2 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.0 |
0.2 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.0 |
0.2 |
GO:0090310 |
negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
| 0.0 |
0.3 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.0 |
0.3 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.0 |
0.8 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.0 |
0.2 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.0 |
0.3 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 0.0 |
2.4 |
GO:0051489 |
regulation of filopodium assembly(GO:0051489) |
| 0.0 |
0.2 |
GO:0042795 |
snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.0 |
0.4 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.0 |
0.2 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.0 |
0.1 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.0 |
0.2 |
GO:0034285 |
response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 0.0 |
0.1 |
GO:0072362 |
regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072362) regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
| 0.0 |
0.1 |
GO:0000393 |
spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.0 |
0.5 |
GO:0042541 |
hemoglobin biosynthetic process(GO:0042541) |
| 0.0 |
1.5 |
GO:0046676 |
negative regulation of insulin secretion(GO:0046676) |
| 0.0 |
0.1 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 0.0 |
0.1 |
GO:0050923 |
regulation of negative chemotaxis(GO:0050923) |
| 0.0 |
0.3 |
GO:0045187 |
regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.0 |
0.1 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.0 |
0.3 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.0 |
0.4 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.0 |
1.3 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.0 |
0.5 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.0 |
0.3 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.0 |
0.1 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.0 |
0.4 |
GO:0048520 |
positive regulation of behavior(GO:0048520) |
| 0.0 |
0.2 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.0 |
0.2 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.0 |
0.1 |
GO:2001180 |
regulation of interleukin-18 production(GO:0032661) negative regulation of interleukin-18 production(GO:0032701) negative regulation of interleukin-10 secretion(GO:2001180) |
| 0.0 |
0.3 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.0 |
0.2 |
GO:1901844 |
regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
| 0.0 |
0.3 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.0 |
0.8 |
GO:0031365 |
N-terminal protein amino acid modification(GO:0031365) |
| 0.0 |
0.0 |
GO:0009301 |
snRNA transcription(GO:0009301) |
| 0.0 |
0.3 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.0 |
0.2 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.0 |
0.1 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.0 |
0.3 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 |
0.2 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.0 |
0.1 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.0 |
0.1 |
GO:0001193 |
maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 0.0 |
0.3 |
GO:0006098 |
pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
| 0.0 |
0.2 |
GO:0045332 |
phospholipid translocation(GO:0045332) |
| 0.0 |
0.3 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
0.4 |
GO:0035886 |
vascular smooth muscle cell differentiation(GO:0035886) |
| 0.0 |
0.1 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
| 0.0 |
0.3 |
GO:0051382 |
kinetochore assembly(GO:0051382) |
| 0.0 |
0.2 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.0 |
0.2 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.0 |
0.9 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 |
0.0 |
GO:0042663 |
regulation of endodermal cell fate specification(GO:0042663) |
| 0.0 |
0.2 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.0 |
0.1 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.0 |
0.1 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.0 |
0.1 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.0 |
0.1 |
GO:1902965 |
protein localization to early endosome(GO:1902946) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.0 |
0.1 |
GO:0035553 |
oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.0 |
0.2 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.0 |
0.2 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.0 |
0.2 |
GO:0070498 |
interleukin-1-mediated signaling pathway(GO:0070498) |
| 0.0 |
0.2 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) cellular response to magnesium ion(GO:0071286) regulation of membrane depolarization during action potential(GO:0098902) regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.0 |
0.1 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.0 |
0.6 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.0 |
0.1 |
GO:0033574 |
response to testosterone(GO:0033574) regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
| 0.0 |
0.3 |
GO:1902230 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.0 |
0.1 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.0 |
0.5 |
GO:0007200 |
phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
| 0.0 |
0.4 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.0 |
0.0 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.0 |
0.3 |
GO:0009303 |
rRNA transcription(GO:0009303) ncRNA transcription(GO:0098781) |
| 0.0 |
0.2 |
GO:0033194 |
response to hydroperoxide(GO:0033194) |
| 0.0 |
0.1 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.0 |
1.7 |
GO:0006275 |
regulation of DNA replication(GO:0006275) |
| 0.0 |
1.5 |
GO:0046488 |
phosphatidylinositol metabolic process(GO:0046488) |
| 0.0 |
0.1 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.0 |
0.7 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.0 |
0.2 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.0 |
0.2 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.0 |
0.0 |
GO:0090037 |
positive regulation of protein kinase C signaling(GO:0090037) |
| 0.0 |
0.1 |
GO:0010715 |
regulation of extracellular matrix disassembly(GO:0010715) |
